| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.5 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |